|

Atezolizumab & Bevacizumab Clinical Trials

4 actively recruiting trials

Also known as: A/B, AVASTIN, AtezoBev, TECENTRIQ

Pipeline

Phase 2: 2Phase 1/2: 1Phase 2/3: 1

Top Sponsors

  • University Health Network, Toronto1
  • Tuen Mun Hospital1
  • Sun Yat-sen University1
  • Michael Dill1

Indications

  • Liver Disease4
  • Liver Cancer4
  • Cancer4
  • Hepatocellular Carcinoma (HCC)3
  • Downstaging1

Other4 trials

Comparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH)
Phase 2/3
Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)
Phase 2
Systemic Chemotherapy With FOLFOX Plus Atezolizumab & Bevacizumab for Patients With Advanced HCC Who Previously Received Atezolizumab & Bevacizumab
Phase 2
Using Radiotherapy and Immunotherapy to Treat Advanced Liver Cancer Before Transplant
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.